Related Experiment Video
Updated: May 23, 2026
10:33
Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
New treatment options for noninfectious uveitis
Millena Gomes Bittencourt1, Yasir Jamal Sepah, Diana V Do
1Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USA.
Developments in Ophthalmology
|April 21, 2012
Summary
New immunosuppressive drugs and advanced drug delivery methods offer improved treatment for autoimmune uveitis, reducing reliance on corticosteroids and minimizing adverse effects for chronic cases.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Autoimmune uveitis involves immune responses to ocular proteins, causing sight-threatening inflammation.
- Corticosteroids are first-line treatment but have significant long-term adverse effects like cataracts and glaucoma.
- Managing chronic uveitis requires alternatives to reduce corticosteroid burden.
Purpose of the Study:
- To review emerging therapeutic strategies for autoimmune uveitis.
- To evaluate novel systemic immunosuppressive drugs and advanced drug delivery systems.
- To explore treatments with potentially fewer side effects and better efficacy for chronic uveitis.
Main Methods:
- Review of current literature on autoimmune uveitis treatments.
- Analysis of new systemic drugs including calcineurin inhibitors (voclosporin), mTOR inhibitors (sirolimus), and IL-1 inhibitors (rilonacept).
- Examination of innovative drug delivery methods such as nanoparticles and iontophoresis.
Main Results:
- New systemic immunosuppressants show promise for managing autoimmune uveitis.
- Advanced drug delivery systems aim for localized treatment and reduced systemic side effects.
- These approaches may offer improved responsiveness and safety profiles for chronic conditions.
Conclusions:
- Emerging therapies present a new horizon for autoimmune uveitis management.
- Reducing corticosteroid dependence is a key goal, with new drugs and delivery methods showing potential.
- Further research and clinical evaluation are ongoing for these novel treatments.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...